Pharmacokinetics of the analgesic and anti-inflammatory drug meloxicam after administration of multiple doses to nursehound sharks (Scyliorhinus stellaris)

To determine the pharmacokinetics of meloxicam in the nursehound shark (Scyliorhinus stellaris) during multiple dose administration. Prospective experimental trial. A total of eight clinically healthy adult nursehounds (four males, four females). Meloxicam was administered intramuscularly at a dose...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Veterinary anaesthesia and analgesia 2024-01, Vol.51 (1), p.71-79
Hauptverfasser: Morón-Elorza, Pablo, Rojo-Solís, Carlos, Álvaro-Álvarez, Teresa, Valls-Torres, Mónica, García-Párraga, Daniel, Encinas, Teresa
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 79
container_issue 1
container_start_page 71
container_title Veterinary anaesthesia and analgesia
container_volume 51
creator Morón-Elorza, Pablo
Rojo-Solís, Carlos
Álvaro-Álvarez, Teresa
Valls-Torres, Mónica
García-Párraga, Daniel
Encinas, Teresa
description To determine the pharmacokinetics of meloxicam in the nursehound shark (Scyliorhinus stellaris) during multiple dose administration. Prospective experimental trial. A total of eight clinically healthy adult nursehounds (four males, four females). Meloxicam was administered intramuscularly at a dose of 1.5 mg kg once daily for 7 days. Blood samples were collected from the caudal vein for pharmacokinetic analysis at 2.5 hours and 24 hours after drug administration. After a 4 week washout period, meloxicam was administered orally at the same dose at 12 hour intervals for three repeated doses. Blood samples were collected at 1, 2, 4, 6, 8, 12, 24, 36 and 48 hours after the first administration. Sharks were visually monitored during each study and 4 weeks afterwards for side effects or signs of toxicity. Time required to achieve steady state was assessed by visual inspection and statistical comparison of peak and trough concentrations using a Friedman test; comparison between sexes was performed using a Mann-Whitney U test and p-value was set at 0.05. No animal died or showed clinical signs of toxicity during the study. Meloxicam administered orally did not produce detectable concentrations in plasma. After intramuscular administration, steady state was achieved after five doses, and mean trough and peak plasma concentrations at steady state were 1.76 ± 0.21 μg mL and 3.02 ± 0.23 μg mL , respectively. Mean peak concentration accumulation ratio was 2.50 ± 0.22. This study shows that intramuscular posology produces plasma concentrations considered therapeutic for other species. However, meloxicam was not detected in plasma after oral administration. These results suggest that meloxicam administered intramuscularly may be a useful non-steroid anti-inflammatory drug in nursehound sharks. Further pharmacodynamic studies are needed to fully evaluate its clinical use in this species.
doi_str_mv 10.1016/j.vaa.2023.09.072
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3153631606</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3153631606</sourcerecordid><originalsourceid>FETCH-LOGICAL-c377t-8f03fbab5b6f99f194c2465ebca92a80d2c95362499e712c59194aa954d525d13</originalsourceid><addsrcrecordid>eNqFkc1u1TAQhSMEoqXwAGyQl2WR4J_YiZeoKj9SJZCAtTVxnF7f2vHF4yDus_Cy-KqlWxajOYtzzoz0Nc1rRjtGmXq3734BdJxy0VHd0YE_ac5Zr4aWay2fPupxOGteIO4pZYOW9HlzJkaq5Mj5efPn6w5yBJvu_OqKt0jSQsrOEVgh3Dr0tqq5TvGtX5cAMUJJ-UjmvN2S6EL67S1EAktxmcAc_eqxZCg-raequIXiD8GROaFDUhJZt4xul7baivX2HZLLb_YYfMo7v25IsLgQIHt8-7J5tkBA9-phXzQ_Plx_v_rU3nz5-Pnq_U1rxTCUdlyoWCaY5KQWrReme8t7Jd1kQXMY6cytlkLxXms3MG6lrhYALftZcjkzcdFc3vcecvq5OSwmerSnL1aXNjSC1bhgiqr_WrmmXCsqNa1Wdm-1OSFmt5hD9hHy0TBqTvjM3lR85oTPUG0qvpp581C_TdHNj4l_vMRfo3SahA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2902960590</pqid></control><display><type>article</type><title>Pharmacokinetics of the analgesic and anti-inflammatory drug meloxicam after administration of multiple doses to nursehound sharks (Scyliorhinus stellaris)</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Morón-Elorza, Pablo ; Rojo-Solís, Carlos ; Álvaro-Álvarez, Teresa ; Valls-Torres, Mónica ; García-Párraga, Daniel ; Encinas, Teresa</creator><creatorcontrib>Morón-Elorza, Pablo ; Rojo-Solís, Carlos ; Álvaro-Álvarez, Teresa ; Valls-Torres, Mónica ; García-Párraga, Daniel ; Encinas, Teresa</creatorcontrib><description>To determine the pharmacokinetics of meloxicam in the nursehound shark (Scyliorhinus stellaris) during multiple dose administration. Prospective experimental trial. A total of eight clinically healthy adult nursehounds (four males, four females). Meloxicam was administered intramuscularly at a dose of 1.5 mg kg once daily for 7 days. Blood samples were collected from the caudal vein for pharmacokinetic analysis at 2.5 hours and 24 hours after drug administration. After a 4 week washout period, meloxicam was administered orally at the same dose at 12 hour intervals for three repeated doses. Blood samples were collected at 1, 2, 4, 6, 8, 12, 24, 36 and 48 hours after the first administration. Sharks were visually monitored during each study and 4 weeks afterwards for side effects or signs of toxicity. Time required to achieve steady state was assessed by visual inspection and statistical comparison of peak and trough concentrations using a Friedman test; comparison between sexes was performed using a Mann-Whitney U test and p-value was set at 0.05. No animal died or showed clinical signs of toxicity during the study. Meloxicam administered orally did not produce detectable concentrations in plasma. After intramuscular administration, steady state was achieved after five doses, and mean trough and peak plasma concentrations at steady state were 1.76 ± 0.21 μg mL and 3.02 ± 0.23 μg mL , respectively. Mean peak concentration accumulation ratio was 2.50 ± 0.22. This study shows that intramuscular posology produces plasma concentrations considered therapeutic for other species. However, meloxicam was not detected in plasma after oral administration. These results suggest that meloxicam administered intramuscularly may be a useful non-steroid anti-inflammatory drug in nursehound sharks. Further pharmacodynamic studies are needed to fully evaluate its clinical use in this species.</description><identifier>ISSN: 1467-2987</identifier><identifier>EISSN: 1467-2995</identifier><identifier>DOI: 10.1016/j.vaa.2023.09.072</identifier><identifier>PMID: 38065822</identifier><language>eng</language><publisher>United States</publisher><subject>Administration, Oral ; adults ; analgesia ; anesthesia ; Animals ; Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics ; Area Under Curve ; blood ; caudal vein ; Female ; Half-Life ; intramuscular injection ; Male ; Meloxicam ; oral administration ; pharmacodynamics ; pharmacokinetics ; Prospective Studies ; Scyliorhinus ; Sharks ; species ; Thiazines ; Thiazoles ; toxicity</subject><ispartof>Veterinary anaesthesia and analgesia, 2024-01, Vol.51 (1), p.71-79</ispartof><rights>Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c377t-8f03fbab5b6f99f194c2465ebca92a80d2c95362499e712c59194aa954d525d13</citedby><cites>FETCH-LOGICAL-c377t-8f03fbab5b6f99f194c2465ebca92a80d2c95362499e712c59194aa954d525d13</cites><orcidid>0000-0003-0198-194X ; 0000-0001-9926-1152</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38065822$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Morón-Elorza, Pablo</creatorcontrib><creatorcontrib>Rojo-Solís, Carlos</creatorcontrib><creatorcontrib>Álvaro-Álvarez, Teresa</creatorcontrib><creatorcontrib>Valls-Torres, Mónica</creatorcontrib><creatorcontrib>García-Párraga, Daniel</creatorcontrib><creatorcontrib>Encinas, Teresa</creatorcontrib><title>Pharmacokinetics of the analgesic and anti-inflammatory drug meloxicam after administration of multiple doses to nursehound sharks (Scyliorhinus stellaris)</title><title>Veterinary anaesthesia and analgesia</title><addtitle>Vet Anaesth Analg</addtitle><description>To determine the pharmacokinetics of meloxicam in the nursehound shark (Scyliorhinus stellaris) during multiple dose administration. Prospective experimental trial. A total of eight clinically healthy adult nursehounds (four males, four females). Meloxicam was administered intramuscularly at a dose of 1.5 mg kg once daily for 7 days. Blood samples were collected from the caudal vein for pharmacokinetic analysis at 2.5 hours and 24 hours after drug administration. After a 4 week washout period, meloxicam was administered orally at the same dose at 12 hour intervals for three repeated doses. Blood samples were collected at 1, 2, 4, 6, 8, 12, 24, 36 and 48 hours after the first administration. Sharks were visually monitored during each study and 4 weeks afterwards for side effects or signs of toxicity. Time required to achieve steady state was assessed by visual inspection and statistical comparison of peak and trough concentrations using a Friedman test; comparison between sexes was performed using a Mann-Whitney U test and p-value was set at 0.05. No animal died or showed clinical signs of toxicity during the study. Meloxicam administered orally did not produce detectable concentrations in plasma. After intramuscular administration, steady state was achieved after five doses, and mean trough and peak plasma concentrations at steady state were 1.76 ± 0.21 μg mL and 3.02 ± 0.23 μg mL , respectively. Mean peak concentration accumulation ratio was 2.50 ± 0.22. This study shows that intramuscular posology produces plasma concentrations considered therapeutic for other species. However, meloxicam was not detected in plasma after oral administration. These results suggest that meloxicam administered intramuscularly may be a useful non-steroid anti-inflammatory drug in nursehound sharks. Further pharmacodynamic studies are needed to fully evaluate its clinical use in this species.</description><subject>Administration, Oral</subject><subject>adults</subject><subject>analgesia</subject><subject>anesthesia</subject><subject>Animals</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics</subject><subject>Area Under Curve</subject><subject>blood</subject><subject>caudal vein</subject><subject>Female</subject><subject>Half-Life</subject><subject>intramuscular injection</subject><subject>Male</subject><subject>Meloxicam</subject><subject>oral administration</subject><subject>pharmacodynamics</subject><subject>pharmacokinetics</subject><subject>Prospective Studies</subject><subject>Scyliorhinus</subject><subject>Sharks</subject><subject>species</subject><subject>Thiazines</subject><subject>Thiazoles</subject><subject>toxicity</subject><issn>1467-2987</issn><issn>1467-2995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1u1TAQhSMEoqXwAGyQl2WR4J_YiZeoKj9SJZCAtTVxnF7f2vHF4yDus_Cy-KqlWxajOYtzzoz0Nc1rRjtGmXq3734BdJxy0VHd0YE_ac5Zr4aWay2fPupxOGteIO4pZYOW9HlzJkaq5Mj5efPn6w5yBJvu_OqKt0jSQsrOEVgh3Dr0tqq5TvGtX5cAMUJJ-UjmvN2S6EL67S1EAktxmcAc_eqxZCg-raequIXiD8GROaFDUhJZt4xul7baivX2HZLLb_YYfMo7v25IsLgQIHt8-7J5tkBA9-phXzQ_Plx_v_rU3nz5-Pnq_U1rxTCUdlyoWCaY5KQWrReme8t7Jd1kQXMY6cytlkLxXms3MG6lrhYALftZcjkzcdFc3vcecvq5OSwmerSnL1aXNjSC1bhgiqr_WrmmXCsqNa1Wdm-1OSFmt5hD9hHy0TBqTvjM3lR85oTPUG0qvpp581C_TdHNj4l_vMRfo3SahA</recordid><startdate>20240101</startdate><enddate>20240101</enddate><creator>Morón-Elorza, Pablo</creator><creator>Rojo-Solís, Carlos</creator><creator>Álvaro-Álvarez, Teresa</creator><creator>Valls-Torres, Mónica</creator><creator>García-Párraga, Daniel</creator><creator>Encinas, Teresa</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7S9</scope><scope>L.6</scope><orcidid>https://orcid.org/0000-0003-0198-194X</orcidid><orcidid>https://orcid.org/0000-0001-9926-1152</orcidid></search><sort><creationdate>20240101</creationdate><title>Pharmacokinetics of the analgesic and anti-inflammatory drug meloxicam after administration of multiple doses to nursehound sharks (Scyliorhinus stellaris)</title><author>Morón-Elorza, Pablo ; Rojo-Solís, Carlos ; Álvaro-Álvarez, Teresa ; Valls-Torres, Mónica ; García-Párraga, Daniel ; Encinas, Teresa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c377t-8f03fbab5b6f99f194c2465ebca92a80d2c95362499e712c59194aa954d525d13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Administration, Oral</topic><topic>adults</topic><topic>analgesia</topic><topic>anesthesia</topic><topic>Animals</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics</topic><topic>Area Under Curve</topic><topic>blood</topic><topic>caudal vein</topic><topic>Female</topic><topic>Half-Life</topic><topic>intramuscular injection</topic><topic>Male</topic><topic>Meloxicam</topic><topic>oral administration</topic><topic>pharmacodynamics</topic><topic>pharmacokinetics</topic><topic>Prospective Studies</topic><topic>Scyliorhinus</topic><topic>Sharks</topic><topic>species</topic><topic>Thiazines</topic><topic>Thiazoles</topic><topic>toxicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Morón-Elorza, Pablo</creatorcontrib><creatorcontrib>Rojo-Solís, Carlos</creatorcontrib><creatorcontrib>Álvaro-Álvarez, Teresa</creatorcontrib><creatorcontrib>Valls-Torres, Mónica</creatorcontrib><creatorcontrib>García-Párraga, Daniel</creatorcontrib><creatorcontrib>Encinas, Teresa</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>AGRICOLA</collection><collection>AGRICOLA - Academic</collection><jtitle>Veterinary anaesthesia and analgesia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Morón-Elorza, Pablo</au><au>Rojo-Solís, Carlos</au><au>Álvaro-Álvarez, Teresa</au><au>Valls-Torres, Mónica</au><au>García-Párraga, Daniel</au><au>Encinas, Teresa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacokinetics of the analgesic and anti-inflammatory drug meloxicam after administration of multiple doses to nursehound sharks (Scyliorhinus stellaris)</atitle><jtitle>Veterinary anaesthesia and analgesia</jtitle><addtitle>Vet Anaesth Analg</addtitle><date>2024-01-01</date><risdate>2024</risdate><volume>51</volume><issue>1</issue><spage>71</spage><epage>79</epage><pages>71-79</pages><issn>1467-2987</issn><eissn>1467-2995</eissn><abstract>To determine the pharmacokinetics of meloxicam in the nursehound shark (Scyliorhinus stellaris) during multiple dose administration. Prospective experimental trial. A total of eight clinically healthy adult nursehounds (four males, four females). Meloxicam was administered intramuscularly at a dose of 1.5 mg kg once daily for 7 days. Blood samples were collected from the caudal vein for pharmacokinetic analysis at 2.5 hours and 24 hours after drug administration. After a 4 week washout period, meloxicam was administered orally at the same dose at 12 hour intervals for three repeated doses. Blood samples were collected at 1, 2, 4, 6, 8, 12, 24, 36 and 48 hours after the first administration. Sharks were visually monitored during each study and 4 weeks afterwards for side effects or signs of toxicity. Time required to achieve steady state was assessed by visual inspection and statistical comparison of peak and trough concentrations using a Friedman test; comparison between sexes was performed using a Mann-Whitney U test and p-value was set at 0.05. No animal died or showed clinical signs of toxicity during the study. Meloxicam administered orally did not produce detectable concentrations in plasma. After intramuscular administration, steady state was achieved after five doses, and mean trough and peak plasma concentrations at steady state were 1.76 ± 0.21 μg mL and 3.02 ± 0.23 μg mL , respectively. Mean peak concentration accumulation ratio was 2.50 ± 0.22. This study shows that intramuscular posology produces plasma concentrations considered therapeutic for other species. However, meloxicam was not detected in plasma after oral administration. These results suggest that meloxicam administered intramuscularly may be a useful non-steroid anti-inflammatory drug in nursehound sharks. Further pharmacodynamic studies are needed to fully evaluate its clinical use in this species.</abstract><cop>United States</cop><pmid>38065822</pmid><doi>10.1016/j.vaa.2023.09.072</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0003-0198-194X</orcidid><orcidid>https://orcid.org/0000-0001-9926-1152</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1467-2987
ispartof Veterinary anaesthesia and analgesia, 2024-01, Vol.51 (1), p.71-79
issn 1467-2987
1467-2995
language eng
recordid cdi_proquest_miscellaneous_3153631606
source MEDLINE; Alma/SFX Local Collection
subjects Administration, Oral
adults
analgesia
anesthesia
Animals
Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics
Area Under Curve
blood
caudal vein
Female
Half-Life
intramuscular injection
Male
Meloxicam
oral administration
pharmacodynamics
pharmacokinetics
Prospective Studies
Scyliorhinus
Sharks
species
Thiazines
Thiazoles
toxicity
title Pharmacokinetics of the analgesic and anti-inflammatory drug meloxicam after administration of multiple doses to nursehound sharks (Scyliorhinus stellaris)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T12%3A39%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacokinetics%20of%20the%20analgesic%20and%20anti-inflammatory%20drug%20meloxicam%20after%20administration%20of%20multiple%20doses%20to%20nursehound%20sharks%20(Scyliorhinus%20stellaris)&rft.jtitle=Veterinary%20anaesthesia%20and%20analgesia&rft.au=Mor%C3%B3n-Elorza,%20Pablo&rft.date=2024-01-01&rft.volume=51&rft.issue=1&rft.spage=71&rft.epage=79&rft.pages=71-79&rft.issn=1467-2987&rft.eissn=1467-2995&rft_id=info:doi/10.1016/j.vaa.2023.09.072&rft_dat=%3Cproquest_cross%3E3153631606%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2902960590&rft_id=info:pmid/38065822&rfr_iscdi=true